...BRCA2.,We sequenced BRCA1/BRCA2 in 1,469 population-based female breast cancer patients diagnosed between the ages of 20...
No formal assessment of life expectancy in women with BRCA1 and BRCA2 mutations in these genes has been reported previou...
...BRCA2 mutation carriers. This is because the relative risk multiplies polygenic risk, and the latter is predicted by fam...
To evaluate the prevalence of BRCA1 and BRCA2 mutations and associations with clinical correlates of disease in a popula...
...BRCA2-deficient mouse mammary tumors and BRCA2-proficient control tumors. Subsequently, we assessed sensitivity of these...
...BRCA2, and, thus, similar phenotypes to tumors with mutant alleles of BRCA1 and BRCA2. This suggests that detection of e...
...BRCA2 pathogenic truncating and missense mutation carriers and familial breast cancer cases whose disease was not attrib...
...BRCA2 mutations. An epigenetic mechanism known to cause inactivation of the MMR system is promoter hypermethylation of 1...
...BRCA2 are high-penetrance breast cancer predisposition genes identified by genome-wide linkage analysis and positional c...
...BRCA2 carcinomas, which tend to be estrogen and progesterone receptor positive. BRCA1 and BRCA2 loss of heterozygosity i...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
